Article
Federal Court Grants Data Protection To THALOMID
In Celgene Inc. v. The Minister of Health, 2012 FC 154, the Federal Court considered a judicial review application challenging the Minister of Health’s refusal to list Celgene’s drug THALOMID on Health Canada’s Register of Innovative Drugs (the "Register").
Heenan Blaikie LLP